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Abstract
U2OS cells harbor a circadian clock but express only a few rhythmic genes in constant conditions. We identified 3040
binding sites of the circadian regulators BMAL1, CLOCK and CRY1 in the U2OS genome. Most binding sites even in
promoters do not correlate with detectable rhythmic transcript levels. Luciferase fusions reveal that the circadian clock
supports robust but low amplitude transcription rhythms of representative promoters. However, rhythmic transcription of
these potentially clock-controlled genes is masked by non-circadian transcription that overwrites the weaker contribution of
the clock in constant conditions. Our data suggest that U2OS cells harbor an intrinsically rather weak circadian oscillator.
The oscillator has the potential to regulate a large number of genes. The contribution of circadian versus non-circadian
transcription is dependent on the metabolic state of the cell and may determine the apparent complexity of the circadian
transcriptome.
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Introduction
Circadian clocks are self-sustained oscillators that depend on
interlocked transcriptional feedback loops. In mammals, the core
loop consists of the transcriptional activators BMAL1 and
CLOCK, which dimerize, bind to E-box elements, and activate
transcription of Cryptochrome (CRY1 and CRY2) and Period
(PER1, PER2, and PER3) genes [1,2]. CRY and PER proteins are
repressors inhibiting the activity of BMAL1/CLOCK [3,4]. In a
second loop ROR activators and REV-ERB repressors regulate
rhythmic transcription of BMAL1 [5–7] and NPAS2 [8] and
presumably also CRY genes [7,9] by competing for ROR elements
[10].
The central circadian pacemaker resides in the suprachiasmatic
nucleus (SCN). It is entrained by the geophysical day/night cycle
of the earth’s rotation through light input received via the
retinohypothalamic tract [11]. Many organs and cell types also
contain a circadian clock [12–15]. These peripheral clocks are
synchronized by the SCN [16] and, in addition, by rhythmic cues
independent of the SCN, such as entrainment by rhythmic feeding
in case of the hepatic clock [17].
Circadian clocks have the potential to drive rhythmic expression
of a large number of clock-controlled genes on a transcriptional
and posttranscriptional level [18–21], which is crucial for circadian
rhythms in physiology and behavior.
In mouse liver, an organ with a highly circadian physiology, up
to ,3700 transcripts are expressed in circadian fashion [19,22–
24]. The rhythmic transcript levels of the core clock genes are
controlled on the level of transcription while abundance rhythms
of more than half of the clock-controlled transcripts may be based
on post-transcriptional regulation [19,20,25]. ChIP-seq analyses
indicate that the core circadian transcription regulators bind in
circadian fashion to several thousand sites in the mouse liver
genome [19,23]. The vast majority of these binding sites cannot be
associated with rhythmic gene transcription, the strongest sites,
however, were highly predictive of rhythmic transcription [23].
In other tissues up to ,10% of the transcriptome is expressed in
circadian fashion but the subsets of rhythmic genes in different
tissues and cell types show little overlap, suggesting tissue-specific
regulation of circadian gene expression [18]. The molecular basis
of tissue specific circadian abundance rhythms of expressed genes
is not understood.
The human osteosarcoma cell line U2OS expresses circadian
clock components that drive oscillation of core clock genes [26,27].
However, it came as a surprise that besides seven rhythmic genes
encoding core circadian clock components no further rhythmic
transcripts had been detected in U2OS cells in a stringent genome-
wide transcriptome analysis [22]. Thus, despite the presence of a
circadian clock in liver and U2OS cells, the complexity of the
circadian transcriptomes appear to be substantially different. We
therefore asked, whether the circadian transcription factors bind to
and regulate fewer genes in U2OS than in liver. We show that
BMAL1, CLOCK, and the circadian repressor CRY1 bind to
about 3000 sites in the genome of U2OS cells, a number similar to
the binding sites identified in mouse liver [19,23]. However, our
own transcriptome analysis showed that only 58 genes with
binding sites are rhythmically expressed, among these 11 genes
encoding core clock components. The majority of promoters with
binding sites do not support rhythmic accumulation of transcripts.
Luciferase fusions with such promoters revealed low amplitude but
robust transcription rhythms that persisted in constant conditions
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in essentially undamped manner for several days. However, non-
circadian transcription activities overwrite the rhythmic contribu-
tion of the circadian clock. Inhibition of metabolism reduced the
clock-dependent and/or independent contribution to transcription
in promoter-specific manner. Our data suggests that isolated
U2OS cells harbor a robust and precise clock. This clock has the
potential to regulate a large number of genes in rhythmic fashion
and with considerable amplitude. The relative activities of
circadian versus gene-specific transcription regulators determine
to the apparent complexity of the circadian transcriptome.
Results
Circadian regulator binding sites
We selected the immortalized human osteosarcoma cell line
U2OS to identify and characterize binding sites of the circadian
transcription factor CLOCK/BMAL1 and its inhibitor CRY1 by
chromatin immunoprecipitation and next generation sequencing
(ChIP-seq). Using affinity purified antibodies (Figure S1A) we
identified 3040 circadian regulator binding sites (CRBSs) in the
genome of unsynchronized U2OS cells (Figure 1A). Examples of
CRBSs in the CRY2 promoter are shown in Figure 1B. A circadian
ChIP-PCR profile of BMAL1 at the promoters of PER2 and
REV/ERBa revealed that the transcription factor interacts
Figure 1. Genome-wide binding sites of the circadian transcription regulators BMAL1 CLOCK and CRY1. (A) Venn diagram showing
numbers and percentage of individual and overlapping binding sites of BMAL1, CLOCK, and CRY1. Percentages represent the fraction of the CRBSs
over the total number of sites for the 3 proteins (B) UCSC browser views of BMAL1 (top), CLOCK (middle) and CRY1 (bottom) occupancy at the
promoter of CRY2. Regions detected as binding sites of the individual transcription regulators are indicated by colored bars. Black bars indicate
common binding sites of the three regulators. (C) CRBSs cluster near TSSs. Histograms of positions of all CRBSs are shown for a window of 620 kb
around TSSs with a bin size of 200 bp. 352 CRBSs are enriched 61 kb around TSS. (D) Histogram of the distance between two consecutive CRBSs
(black) in comparison to a set of 3040 random sites (red). (E) Pie chart showing the percentage of binding sites in a genomic region (black) and the
contribution of the region (%) to the genome (grey). (F) Genomic annotation of the CRBSs to promoter (21 kb to TSS), 59UTR, exon, intron, 39UTR,
and intergenic region.
doi:10.1371/journal.pone.0102238.g001
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rhythmically and with high amplitude with the CRBSs (Figure
S1B).
The CRBSs were highly enriched at transcription start sites
(TSSs) (Figure 1C). The median distance between CRBSs was
47 kb (Figure 1D), indicating that the sites were not randomly
distributed in the genome. The majority of the CRBSs was located
in intergenic regions (49.3%) and introns (28.4%), and 7.5% of the
CRBSs were in promoters (Figure 1E). Taking in consideration
that intergenic regions and introns make up 64.1% and 27.1% of
the genome, respectively, CRBSs were highly enriched in
promoters (Figure 1F).
Sequence analysis of the CRBSs revealed an enrichment of E-
box motifs, in particular CACGTG, CATGTG and CAGGTG,
and tandem E-boxes with a 6 bp spacer (Figures S2), in agreement
with previous data from mouse liver [23].
Recently it has been reported that CRYs also interact with the
glucocorticoid receptor [28]. Glucocorticoid receptor response
elements (GREs) were not enriched in the CRY1 binding sites
suggesting that interaction with the glucocorticoid receptor may
not be a major pathway of CRY1 recruitment to chromatin in
U2OS cells.
Rhythmic gene expression
Each CRBS was attributed to the gene with the closest TSS
using the RefSeq gene annotation. By this means we defined 1373
genes with binding sites (Dataset S1).
We then analyzed the temporal expression profiles of genes with
CRBSs. For control we analyzed expression of a randomly chosen
set of 3480 genes (random genes). In addition, we selected and
analyzed 1503 genes that are implied in different cellular
pathways, including the circadian clock genes CLOCK, BMAL1,
E4BP4, and NPAS2.
U2OS cells were entrained for 5 days with temperature cycles
(12 h, 33uC/12 h, 37uC) and then released to constant conditions
(37uC). Samples were harvested at three-hour intervals for two
consecutive days. We performed two independent experiments
using two entrainment protocols (Materials and methods). 58
genes with CRBSs, and 60 genes without CRBSs were rhythmi-
cally expressed in both experiments (Figure 2, Figure S3). The
proportion of rhythmic genes with a CRBS for any of the
regulators was similar to the proportion of rhythmic genes with
CRBSs for all regulators. By extrapolation, we estimate that about
0.9–1.2% of the genes are rhythmically expressed in U2OS cells.
Amongst the rhythmic genes with CRBSs were the circadian genes
CRY1, CRY2, DEC1, DEC2, DBP, PER1, PER2, PER3, REVERBa,
REVERBb and TEF, which are regulated by BMAL1/CLOCK
(Figure 3A and S4A). In the group of rhythmic genes without
CRBSs were BMAL1, E4BP4, and NPAS2 (Figure 3B and S4B).
Thus, virtually all known rhythmic clock genes were detected,
indicating that the expression analysis was suitable for the
detection of circadian genes. Expression rhythms of these core
clock genes oscillated with about 4-fold amplitude (peak: trough).
The CLOCK gene did not qualify as a rhythmic gene by our
criteria (Figure 3B). Examples of rhythmic genes with and without
CRBSs and non-rhythmic genes are shown in Figure 3C–E and
Figures S3 and S4C–E.
A plot of the amplitude versus the circadian phase revealed that
rhythmic genes were expressed at two phases (,CT15 and,CT3)
and displayed generally rather low amplitude rhythms (Figure 4A).
The peak at ,CT3 contained all known core clock genes that are
controlled by BMAL1/CLOCK (Figure 4B and C). Correspond-
ing data for array B are shown in Figure S5.
We then divided the group of genes with CRBSs (n= 1373) into
two categories, genes with at least one CRBS close to the TSS (61
kb, n = 352) or only distant CRBSs (n= 1021). The fraction of
rhythmic genes with distant CRBSs was 3.2%, while 7.9% of the
genes with a CRBS close to the TSS were rhythmic (Figure S6, p,
0.001). Thus, rhythmic gene expression correlates with the
proximity of CRBSs to the TSS. Yet, most genes with CRBSs,
even genes with highly enriched binding sites in their promoters,
appeared not to be rhythmically expressed in U2OS cells.
In summary, U2OS cells express only a few rhythmic genes
(,1%). Core clock genes are generally expressed with readily
detectable rhythms. Yet, the amplitudes (,4x) are much lower than
corresponding amplitudes in liver of living mice [19,22,24,25].
Circadian and non-circadian contributions to gene
expression
The promoters of ATG3, EIFA2, and SCN5A contain highly
enriched binding sites close to their TSSs (Figure 5A) but did not
qualify in the expression array analysis as rhythmic genes by our
criteria (Figure 5B). preRNA and mRNA profiles (Figure 5C and
D) indicate that ATG3, EIF5A2 and SCN5A are not transcribed
Figure 2. Heat map view of 24 h cycling genes. Rhythmic genes
with CRBSs (A) and without CRBSs (B) were ordered by phase of
expression. Temperature entrained U2OS cells were released into
constant conditions (37uC) and RNA expression levels were analyzed in
3 h intervals over a period of two days.
doi:10.1371/journal.pone.0102238.g002
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Figure 3. Temporal expression profiles of rhythmic and non-rhythmic genes. RNA levels of U2OS cells were analyzed in 3 h intervals over a
period of two days. Expression ratios of each time point (0–45 h) relative to the average were calculated and plotted on a log2 scale versus the
circadian time (CT). For each gene up to 10 probes were spotted on the arrays. Light blue lines correspond to expression profiles based on individual
probes. The black triangles and the fitted dark blue sine curve correspond to the median of the data. Light and dark areas in the background indicate
subjective day and night, respectively. Examples are shown for genes that fall in various categories. (A) Clock genes with CRBSs. (B) Clock-genes
Circadian Gene Expression in U2OS Cells
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with a significant rhythm in U2OS cells. In contrast to U2OS cells,
the strongest binding sites in mouse liver correlate well with
rhythmic transcript levels [19,23].
We generated stable reporter cell lines expressing a PEST-
destabilized luciferase (LUC2P) under control of the promoters of
ATG3, EIF5A2, SCN5A and GAPDH (promoter with no CRBS) and
analyzed luciferase activity in comparison with BMAL-luc and
PER2-luc2 reporter cell lines. The raw data (Figure 6, left) revealed
that the promoters of ATG3, EIF5A2 and SCN5A supported, like
BMAL1 and PER2, rhythmic luciferase expression. The temporal
expression profiles were composed of an apparent non-circadian
and a circadian component (Figure 6 middle and right). The non-
circadian contributions to the temporal transcription profiles (24 h
moving average) were promoter-specific and hence not entirely
due to desychronization of cells. The non-circadian component
was at all times stronger than the circadian component, resulting
in severely blunted expression rhythms of ATG3, EIF5A2 and
SCN5A. The relative amplitudes (peak: trough) of the circadian
transcription rhythms of the ATG3, EIF5A2 and SCN5A reporters
were low. Hence, expression of these clock-controlled reporter
genes was apparently arrhythmic despite absolute amplitudes
(peak – trough) similar or higher than those supported by BMAL1-
luc and PER2-luc2. In contrast, the non-circadian contributions to
luciferase expression by BMAL1 and to a lesser extent by PER2 was
rather low and therefore these genes displayed circadian oscilla-
tions with significant amplitudes (peak: trough). Interestingly, the
luciferase rhythms of ATG3, EIF5A2 and SCN5A did not
substantially dampen while the rhythms of BMAL1 and PER2
damped extensively during the same time period. The data
suggests that the high amplitudes of the BMAL1 and PER2
oscillations were evoked by the synchronizing dexamethasone
pulse given at the beginning of the measurement. GAPDH-luc2P
expression was essentially arrhythmic.
The non-circadian components of the temporal expression
profiles (Figure 6, middle panels) might be driven by promoter-
specific transcription regulators. Such factors could respond in
complex fashion to the temporally changing conditions in the 96-
well plates that may challenge metabolism and cellular homeo-
stasis. Since we have no means of changing the non-circadian
versus circadian contribution to the expression of these genes in a
specific manner we attempted to globally unbalance transcription.
Rapamycin is a potent inhibitor of mTORC1 that regulates many
aspects of metabolism [29] and may directly and indirectly affect
expression of many genes. Hence, we incubated the reporter cell
lines with rapamycin. The treatment did not significantly affect
growth of the U2OS cells (Figure S7) but lengthened the circadian
period by about ,1.5 h (Figure 6, grey versus black traces).
Rapamycin reduced the average expression levels of the PER2,
ATG3, EIF5A2 SCN5A and GAPDH reporters but had no effect on
the BMAL1-luc expression level and the amplitude of the rhythm
(Figure 6). Rapamycin generally stabilized the temporal luciferase
expression profiles of the reporters but had little or no effect on the
absolute amplitudes (peak – trough) of the transcription rhythms.
Accordingly, the relative amplitudes (peak: trough) supported by
the promoters of ATG3, EIF5A2 SCN5A and PER2 increased in the
presence of rapamycin. The data suggest that these promoters are
regulated by circadian and non-circadian factors, which respond
in promoter-specific manner to the inhibition of mTORC1.
Together, the data suggests that promoters with binding sites for
BMAL1/CLOCK support in principle rhythmic transcription.
The rhythmic accumulation of transcript levels appears to be
dependent on the activity of the circadian transcription factors
without CRBSs. (C) Rhythmic genes with CRBSs. (D) Rhythmic genes without CRBSs. (E) Genes not expressed in a rhythmic fashion. AGAP11 harbors a
highly enriched binding site for BMAL1, CLOCK, and CRY1, CHP has a CRY1 binding site. In both genes the CRBSs were close to the TSS. CSNK2B and
KDELR1 do not have a CRBS in a window of 620 kb.
doi:10.1371/journal.pone.0102238.g003
Figure 4. mRNA expression phase and correlations with CRBSs.
Analysis of temporal expression profiles of 5708 expressed genes in two
microarray replicates identified 118 common genes with circadian
expression rhythms. Data from array A is shown. (A) The amplitudes of
expressed genes (n = 5708) were plotted versus the circadian phase.
The 118 rhythmic genes are indicated by black symbols. The shade of
blue corresponds to the rhythmicity of a gene (light blue= low 24 h-
rhythmicity and/or phase undefined; dark blue= high 24 h-rhythmicity
and highly reliable phase). (B) The amplitudes of the 118 rhythmic
genes are plotted against the phase. Genes with CRBSs are shown with
black diamonds, the other rhythmic genes are displayed with gray
diamonds. Core circadian clock genes are indicated. (C) Phase
distribution of rhythmic genes with and without CRBSs.
doi:10.1371/journal.pone.0102238.g004
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versus genes specific, non-circadian transcription regulators. The
data are compatible with the notion that U2OS cells harbor a
rather weak circadian oscillator. This oscillator supports transcrip-
tion rhythms with low amplitudes relative to the non-circadian
expression levels of the clock-controlled genes.
Discussion
Circadian oscillators in different cell types are composed of
essentially identical components. Yet, the repertoires of clock-
controlled genes as well as their expression amplitudes can differ
between cell types or organs. We have correlated binding of
circadian transcription regulators to the genome of U2OS cells
Figure 5. Expression analysis of genes with CRBSs in their promoters. (A) UCSC browser views of BMAL1 (top), CLOCK (middle) and CRY1
(bottom) occupancy at the promoters of ATG3, EIF5A2, and SCN5A. Binding sites of the individual transcription regulators are indicated by colored
bars. Black bars indicate common binding sites of the three regulators. (B) Temporal expression profiles (microarray analysis) of ATG3, EIF5A2, and
SCN5A, which have strong CRBSs in their promoters. (C, D) Around the clock qRT-PCR analysis of preRNA (C) and mRNA (D) levels of ATG3, EIF5A2,
and SCN5A. qRT-PCR analysis was carried out with intron- and exon-specific probes, respectively, of ATG3, EIF5A2, and SCN5A using RNA of time
courses A and B. Expression levels of HPRT1 were used for normalization.
doi:10.1371/journal.pone.0102238.g005
Circadian Gene Expression in U2OS Cells
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e102238
Figure 6. Rhythmic transcription of genes with CRBSs in their promoter is masked by high baseline expression. Robust low amplitude
transcription rhythms revealed by long-term luminescence measurements of stable U2OS cell lines expressing the destabilized luciferase2P (luc2P)
under control of the promoters of ATG3, EIF5A2, and SCN5A. BMAL1-luc, PER2-luc2, and GAPDH-luc2P cell lines are shown for control. Luminescence of
synchronized cultures was measured at 30 min intervals. Raw expression data of the indicated reporter genes for day 1 to day 5 after synchronization
are shown in the left panels. The middle panels show the 24 h moving average of the luciferase activity to estimate the non-rhythmic contribution
and the right panels show the de-trended data to estimate the rhythmic contribution. The black and grey traces show expression profiles in the
absence and presence of 200 nM rapamycin, respectively.
doi:10.1371/journal.pone.0102238.g006
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with circadian expression rhythms of genes with such binding sites.
The circadian regulators BMAL1, CLOCK, and CRY1 bound to
several thousand sites (3040) in the U2OS genome. However, only
58 genes with CRBSs (including 11 core clock genes) were
rhythmically expressed with significant, yet low amplitudes. Based
on the analysis of a set of randomly chosen genes we extrapolate
that U2OS cells may express about 300 genes in rhythmic fashion
with detectable amplitudes. Our data are in principle consistent
with data of a previous genome-wide expression analysis of U2OS
cells, reporting that only the transcript levels of seven core clock
genes oscillate in circadian fashion with significant amplitudes
[22]. Our study indicates that U2OS cells rhythmically express
core clock genes and in addition a rather small number of clock-
controlled genes that oscillate with very low amplitudes.
The number of cycling transcripts in mouse liver is about an
order of magnitude higher than in U2OS cells and levels of most
clock-controlled liver transcripts oscillate with higher amplitude
[19,22,24,25,30]. Also the SCN expresses ccgs in rhythmic fashion
and with high amplitudes [18]. Why is the number of apparently
rhythmic transcripts so low in U2OS cells?
We show that BMAL1 and CLOCK sites were highly enriched
at TSSs, although to a somewhat lesser extent than in mouse liver
[19,23]. Yet, not even genes with strong CRBSs in their promoter
displayed detectable circadian expression rhythms in constant
conditions. Luciferase gene fusions of promoters with CRBSs
revealed that the corresponding reporter genes were in fact
expressed in circadian fashion. Since the promoter-luciferase
fusion genes express approximately identical mRNAs the lucifer-
ase activity rhythms should essentially reflect transcription
independent of posttranscriptional processes. It is therefore highly
likely that promoters with CRBSs are rhythmically transcribed in
U2OS cells. Given the number of CRBSs and their enrichment in
promoters, U2OS cells may support rhythmic transcription of a
similarly large number of genes as liver or the SCN. However, the
amplitudes of the luciferase rhythms (peak: trough) were low in
relation to the mean expression levels of the reporter genes. Low
amplitude expression rhythms may however not be detected with
statistical significance in genome-wide approaches like expression
arrays.
Why are the amplitudes of rhythmic transcript levels low in
U2OS cells and high in mouse liver in vivo? Reasons might be
found on the level of a single cell and/or on the level of the
population of cells. On the level of an individual cell, the strength
or capacity of the circadian oscillator may depend in complex
manner on expression levels and ratios of core and accessory clock
components. The expression levels and amplitudes of the core
clock genes are lower in U2OS cells than in liver [19,22,24,25,30],
suggesting that U2OS cells may harbor a rather weak circadian
oscillator, which may not have the capacity to support high
amplitude rhythms of ccgs. On the systemic level, the dexameth-
asone pulse may only inefficiently synchronize the population of
U2OS cells, which could explain the low amplitude circadian
expression rhythms. However, it should be noted that the
substantial dampening of the BMAL1-luc and PER2-luc rhythms
after synchronization of the U2OS cells with dexamethasone does
not reflect desynchronization of cells since the oscillations of the
ATG3, EIF5A2, and SCN5A reporters rhythms persist during the
same time period in essentially undamped manner. Furthermore,
when cells desynchronize, the oscillation of BMAL1-luc and PER2-
luc should dampen around a constant mean expression level,
which is not the case. Rather, the initially high peak expression
levels of BMAL1-luc and PER2-luc rhythms appear to be directly
triggered by the dexamethasone pulse given at the beginning of the
recording period. In mouse, several clock genes, including Bmal1
and Per2 respond to the glucocorticoid receptor [31]. The
dexamethasone pulse induced transcription of BMAL1-luc and
PER2-luc at levels that are higher than the expression levels
supported by the circadian clock in constant conditions. The
dampening of the BMAL1-luc and PER2-luc rhythms in the course
of several days may reflect aftereffects of the dexamethasone pulse.
At day one, dexamethasone induced expression of EIF5A2 and
PER2 in a similar manner but did not affect expression of ATG3
and SCN5A, suggesting that entraining cues may directly induce
transcription of core clock genes and also of specific ccgs.
A weak oscillator in U2OS cells can only in part explain the low
number of robustly cycling genes in U2OS cells since the U2OS
clock is sufficiently strong to support transcription rhythms of the
ATG3, EIF5A2, and SCN5A reporters with absolute amplitudes
(peak – trough) equal or higher than those of the BMAL1 and
PER2 promoters. Since the relative amplitudes (peak: trough) of
the ATG3, EIF5A2, and SCN5A reporters are low, our data suggest
that transcription of the ccgs is supported by additional, clock-
independent factors. These components determine transcription
levels in promoter-specific manner and mask the weaker
contribution of the circadian clock.
It seems therefore conceivable that the apparent complexity of
the rhythmic transcriptome of a cell is dependent on the strength
of the circadian clock (e.g. expression levels and ratios of clock
components) in comparison to the activity of non-circadian
transcription factors regulating gene expression according to acute
environmental conditions and in cell-type specific manner.
Materials and Methods
Antibodies
For all ChIPs, polyclonal anti-rabbit antibodies were raised by
Pineda Antiko¨rper-Service, Berlin, Germany and purified using
standard techniques. BMAL1 was raised against a C-terminal
peptide CLEADAGLGGPVDFSDLPWPL [23], CRY1 against
the C-terminal peptide CQEEDTQSIGPKVQRQSTN and
CLOCK against the N-terminal peptide CIFDGLVEEDDKD-
KAKRVS.
ChIP protocol
Synchronized U2OS cells were fixed in 1% formaldehyde for
10 minutes followed by quenching in 125 mM glycine. After
scraping cell were washed several times with PBS and then washed
twice with cold IP buffer (50 mM Tris, pH 7.5, 150 mM NaCl,
5 mM EDTA, 0.5% NP40, 0.1% triton-X 100). Chromatin was
sonicated using a Bioruptor (Diagenode Inc.) to obtain 200–
1000 bp DNA fragments (30 sec on, 30 sec off cycles for 20 min
on high power). Samples were incubated overnight with BMAL1
antibody followed by 2 hr incubation with protein A agarose
beads (Millipore). After several washes with IP buffer, samples
were boiled for 10 min in 10% Chelex (Bio-Rad) with Proteinase
K (150 mg/mL) and spinned down. DNA-containing supernatant
was collected for qPCR and values were normalized to percentage
of input. Circadian analysis was performed using CircWave
software.
Chromatin Immunoprecipitation for ChIP-sequencing was
performed as described previously [23] using confluent desyn-
chronized U2OS cells and BMAL1, CLOCK, and CRY1-
antibodies. Immunoprecipitated chromatin (10 ng DNA of 8
independent BMAL1 ChIPs with enrichment levels .80-fold,
9 ng DNA of a CRY1 ChIP with 10-fold enrichment, and 8 ng
DNA of a CLOCK ChIP with 40-fold enrichment) was used for
library preparation with the ChIP-Seq Sample Preparation Kit
(Illumina) and samples were quantified using a Qubit fluorometer
Circadian Gene Expression in U2OS Cells
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(Invitrogen). Three lanes of the BMAL1 library, and one lane each
of the CRY1 and CLOCK library were sequenced on the Illumina
Genome Analyzer IIx using Single-Read Cluster Generation Kit
and 36 Cycle Sequencing Kit v2 (Lausanne Genomics Technol-
ogies Facility). Data were processed using the Illumina Pipeline
Software v1.40.
ChIP-sequencing data analysis
Sequenced DNA reads (Illumina, 38 bases long reads) were
mapped to the human genome (Homo Sapiens Genome Reference
Consortium Human Build 37 [GRCh37/hg19; Feb. 2009]) using
Bowtie with maximally two mismatches and only one hit allowed
on the genome. Redundant tags that mapped to the same genomic
position and on the same strand were considered PCR duplicates
and only one read was kept for analysis. Each lane of the BMAL1
ChIP-Seq yielded 1.66107 reads, the CLOCK ChIP-Seq
2.16107, and the CRY1 ChIP-Seq 2.56107.
Circadian regulator binding site identification
For each protein separately, BMAL1 or CLOCK or CRY1-
bound regions were detected by MACS [32] with the following
parameters: shift = 70 bp (BMAL1), 90 bp (CLOCK) and 100 bp
(CRY1), bandwidth = 26shift, genome size = 2.16 Gb, and an
input chromatin sample from human 293T cells as control data.
This yielded a total of 9459 regions bound by at least one protein.
A refined estimate of the binding site location in each of these
regions was then obtained by a deconvolution algorithm that
models the expected distribution of tags on the positive and
negative strands [23]. This was done separately for each protein in
order to accurately detect the genomic location of the bound
protein. For the rest of the analysis, local maxima in the
deconvoluted signal were used as the center positions of the
binding sites. The deconvolution methods also provides a goodness
of fit score that quantifies whether the plus and minus tag
distributions fit the expected patterns [23]. This score was used to
reject spurious sites. The binding sites were then attributed a score
that combines the enrichment in tag counts in window of6100 bp
around their center compared to input chromatin, as well as the
goodness of fit criterion.
The overlaps between the binding sites of the three proteins
were computed using the command ‘‘intersectBed’’ from the
BedTools suite [33].
Each binding site was annotated with the RefSeq gene having
the closest TSS.
Visualization of the ChIP-seq and of the detected binding sites
for each protein can be found on the following UCSC genome
browser session:
http://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=
submit&hgS_otherUserName= laurasymul&hgS_otherUserSession
Name=Stefanski_et_al_2013.
Microarray design
A 60 k customized microarray was designed for 6356 genes,
which corresponds to roughly one fourth of the human genome.
1373 genes were assigned to CRBSs, 1503 genes were specifically
selected in addition to a set of 3480 random genes. For each gene
10 independent probes were designed to increase reliability of the
data.
Two 48-hour time courses were performed as described in the
Time courses section and cell pellets were harvested every 3 hours.
RNA was purified and samples were labeled with the Two-Color
Low Input Quick Labeling kit (Agilent) according to the provided
protocol. Samples were labeled in two colors to allow a
comparison of RNA amounts from each of the 16 time points
(labeled individually with Cyanine-5 (Cy5)) to the average of all
time points (labeled together with Cy3). The GEO accession
number for the microarray results is GSE57891.
Microarray analysis
After rejecting probes with too low absolute hybridization
signals (less than 20 fold of the median signal of negative control
probes), the raw ratio data of the two independent 48 h time-
courses was analyzed. Genes with less than two valid.
probes were rejected from the analysis. For each gene, the
median ratio of all remaining probes was then used as relative
expression measure of one probeset at each time point. For the
identification of rhythmic probesets, the Fisher test was used as
described [23,25]. To be stringent the following combined filters
were used: the Fisher test p-value needed to pass a threshold of a
FDR (False Discovery Rate) [34] of 20% in at least one of the two
arrays, and of 50% in both arrays; the amplitude needed to be
higher than 0.25 in log2 scale on both arrays, which corresponds
to a 1.2-fold change from peak to trough; given that the signal for
one gene consisted of the median of at least 3 probes and at most
10 probes, sufficient correlation between these probes was ensured
by requiring that the temporal average of the standard deviation
between the probes does not exceed 33% of the amplitude of the
median signal; the phase of a given gene needed to be comparable
in both arrays, allowing for a deviation of 63 h between both
arrays. Together, this analysis yielded a set of 118 robustly
rhythmic transcripts.
Real-time bioluminescence monitoring
30,000 cells/well were split into a 96-well plate the day before
the experiment. Before measuring the luminescence, medium was
exchanged to DMEM (w/o Phenolred) supplemented with 10%
FCS, Hepes (25 mM), luciferin (0.125 mM; P.J.K), Penicillin/
Streptomycin. Bioluminescence was recorded every 30 min at
37uC for at least 6 days with an EnVision Xcite Multilabel Reader
(Perkin Elmer) and analyzed by the MultiCycle software (Acti-
metrics). All chemicals were obtained from PAA, if not indicated
differently.
Cell lines
U2OS cells (ATCC # HTB-96) and the thereof derived U2OS
BMAL-luc cells were described previously [27]. Stable cell lines
expressing the promoter-luciferase constructs were generated using
retroviral transduction with the pV Pack Eco System (Agilent)
according to the manufacturer’s protocol. For lentiviral transduc-
tion a modified U2OS cell line, which overexpresses the murine
MCAT receptor, U2OS-mcat, had been engineered using
selection with the antibiotic zeocin. After transduction single cell
clones were sorted using the FACSAria (BD Bioscience) and
grown in tissue culture. The clones were then selected for
luminescence using the EnVision Xcite system (PerkinElmer).
Promoter-luciferase constructs are described in the Supporting
information.
Plasmids and oligonucleotides
Promoter-luciferase constructs were bought from SwitchGear
Genomics for ATG3 (product ID 108396), EIF5A2 (product ID
106995), SCN5A (product ID 109730), and GAPDH (product ID
121624). They harbor roughly 1 kb upstream genomic sequences
of respected genes and contain the ChIpped CRBSs: (ATG3
113763005-113763997 bp (- strand; chr3), EIF5A2 172109014-
172109967 bp (- strand; chr3), GAPDH 6513163-6514226 bp (+
strand; chr12), SCN5A 38665940-38666935 bp (- strand; chr3)).
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The fragments are coupled to the destabilized luciferase LUC2P
from Promega. The promoter for PER2 (2848 bp to +204 bp
from TSS) was amplified from U2OS genomic DNA and cloned
into the pGL4.20 vector (Promega), which expresses luc2. All
promoter-luciferase constructs were cloned into a pSIN-derived
vector for retroviral transduction using the restriction enzymes
BamHI and MluI. For each reporter, several independent clones
with different expression levels were tested to exclude possible
insertional effects.
For qRT-PCR quantification of the BMAL1, HPRT1, GAPDH,
and PER1 genes 59FAM, 39TAMRA labeled oligos were used.
Probes from the Universal Probe Library (Roche) were applied for
preRNA and RNA detection of the other genes.
qRT-PCR was performed on the Roche Light Cycler 480 using
the TaqMan Gene Expression Master Mix from Applied
Biosystems for ChIP-enrichment and RNA measurements and
the TaqMan Fast Advanced Master Mix from Life Technologies
Table 1. Sequences of primers and probes for q-RT-PCR.
BMAL1_F 59-gaagacaacgaaccagacaatgag-39
BMAL1_R 59-catgagaatgcagtcgtccaa-39
BMAL1_probe 59-tgtaacctcagctgcctcgtcgca-39
GAPDH_FWD 59-catcaatggaaatcccatca-39
GAPDH_REV 59-gactccacgacgtactcagc-39
GAPDH_probe 59-FAM-tccaggagcgagatccctcca-TAMRA-39
GAPDH_gDNA_F 59-catcaatggaaatcccatca-39
GAPDH_gDNA R 59-ttctccatggtggtgaagac-39
GAPDH_gDNA_probe 59-FAM-tactcagcgccagcatcgcc-TAMRA-39
PER1_F 59-agacctctcagcctatgagaaagc-39
PER1_R 59-cccgacctgccaagattg-39
PER1_probe 59-FAM-tggagagcgggactggcatttacg-TAMRA-39
HPRT1_F 59-ctggcgtcgtgattagtgat-39
PER2_F 59-ctatgtgacagcggcgact-39
PER2 R 59-gctgcacgtatcccctca-39
PER2 probe UPL-70
NR1D1 F 59-tgcgtttgttttcattcagc-39
NR1D1 R 59-gggcggagctcattatgtaac-39
NR1D1 probe UPL-87
HPRT1_R 59-ctcgagcaagacgttcagtc-39
HPRT1_probe 59-FAM-caccctttccaaatcctcagcataatg-TAMRA-39
ATG3_F 59-aacagtgaccattgaaaatcacc-39
ATG3_R 59-gattttcttcatcacctcagcat-39
ATG_probe UPL-87
EIF5A2_F 59-ttagcctcggcaaaccaa-39
EIF5A2_R 59-cttgtgctttagaaatttcctttgt-39
EIF5A2_probe UPL-60
SCN5A_FWD 59-gagcaacttgtcggtgctg-39
SCN5A_REV 59-gatttggccagcttgaagac-39
SCN5A_probe UPL-12
ATG3_intron_R 59-cacatggtatcagttggacaaaa-39
ATG3_intron_probe UPL-26
BMAL1_intron_F 59-ctaggcagtacaagaaccaaaagac-39
BMAL1_intron_R 59-gatgaatgtagcttttgggtgac-39
BMAL1_intron_probe UPL-25
EIF5A2_intron_F 59-gattacaggcctgagcaagg-39
EIF5A2_intron_R 59-tccactagcatcatttcttacctg-39
EIF5A2_intron_probe UPL-23
SCN5A_intron_F 59-gggtgggaggtcaaactgt-39
SCN5A_intron_R 59-ctctgtgcatcccctctagc-39
SCN5A_intron_probe UPL-87
doi:10.1371/journal.pone.0102238.t001
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for pre-mRNA measurements. Sequences of primers and probes
for q-RT-PCR are listed in Table 1.
Time courses
For temperature entrainment U2OS cells were incubated at
alternating 12 h, 33uC and 12 h, 37uC cycles. Medium changes
were carried out at the transition from 33uC to 37uC. When used
on luciferase reporter cell lines, this method gave similar results to
dexamethasone synchronization. For time course A, cells were
pre-incubated under temperature entrainment for 4 days. On day
5, 160,000 cells/well were seeded in 35 mm dishes and grown for
5 more days under temperature entrainment until they reached
confluence. Growth medium was exchanged directly before the
cells were released to constant 37uC.
24 h and 48 h after medium change cells were harvested at 3 h
intervals for 24 h. RNA was isolated using the RNeasy kit
(Qiagen).
The time course for array B was carried out similarly, with the
exception that cells were incubated in two incubators with
opposite temperature rhythms and harvested for 12 h on two days.
Supporting Information
Figure S1 Circadian binding profile of BMAL1. (A) The
specificity of antibodies against BMAL1, CLOCK, and CRY1 was
analyzed by Western-blotting of U2OS cell lysates, comparing
serum (1:1000), peptide-blocked serum (serum: 1:1000, peptide:
10 mg/ml), and affinity-purified antibody.(B) Rhythmic BMAL1
occupancy on the promoters of PER2 and REV-ERBa genes in
synchronized U2OS cells. Cell were synchronized with temper-
ature cycles (12 hours of 33uC–12 hours of 37uC) and then
released to a constant temperature of 37uC. Samples were
collected at four different time points as indicated (n= 3). The
CIRCWAVE p values for BMAL1 binding to the PER2 and REV-
ERBa promoters were 0.0016 and 0.000004 respectively.
(TIFF)
Figure S2 E-box and double E-box motifs are enriched
in BMAL1 and CLOCK binding sites and around the
TSS. (A) Upper panel: Sequence logos of E-box motifs enriched in
CRBSs. One and two mismatch was allowed. Lower panel:
Enrichment of CRBSs containing the indicated E-box motifs
(black columns). To control for bias due to sequence composition,
the sequences were randomly shuffled and analyzed for E-box
motifs (grey columns). At least one of the three E-box variants
CACGTG, CATGTG and CAGGTG was found in 43% of the
CRBSs. (B) Tandem E-boxes with a spacer of 6 bp are enriched in
CRBSs. Upper panel: Sequence logos of double E-box motifs.
Lower panel: Autocorrelation analysis of E-boxes (23).
(TIFF)
Figure S3 Temporal expression profiles of 118 rhyth-
mic genes. RNA levels of temperature entrained U2OS cells
were analyzed in 3 h intervals over a period of two days in
constant conditions (Materials and methods). For each gene the
expression ratios of each time point (0–45 h) relative to the
average expression level were calculated and plotted on a log2
scale versus the circadian time (CT). For each gene up to 10
probes were spotted on the arrays. Light blue lines indicate the
expression profiles based on individual probes. The black triangles
and the fitted dark blue sine curves correspond to the median of
the data. Light and dark areas in the background indicate
subjective day and night, respectively. Data from array A (left
panels) and array B (right panels) is shown.
(PDF)
Figure S4 Temporal expression profiles of selected
rhythmic and non-rhythmic genes. This figure presents data
from array B that is complementary to data from array A shown in
Figure 4. Examples are shown that fall in various categories. (A)
Clock genes with CRBSs. (B) Clock-genes without CRBSs. (C)
Rhythmic genes with CRBSs. (D) Rhythmic genes without
CRBSs. (E) Genes not expressed in rhythmic fashion. AGAP11
harbors a high scoring binding site for BMAL1, CLOCK, and
CRY1, CHP has a CRY1 binding site. In both genes the CRBSs
were close to the TSS. CSNK2B and KDELR1 do not have a
CRBS.
(TIFF)
Figure S5 mRNA expression phase and correlations
with CRBSs. This figure presents data from array B that is
complementary to data from array A shown in Figure 5. Analysis
of temporal expression profiles of 5708 expressed genes in two
microarray replicates identified 118 common genes with diurnal
expression rhythms. (A) The amplitude of a gene (n = 5708) was
plotted versus the circadian phase. The 118 rhythmic genes are
indicated by black symbols. The shade of blue corresponds to the
rhythmicity of a gene; light blue = low 24 h-rhythmicity and/or
high variation in phase; dark blue = high 24 h-rhythmicity and
highly reliable phase. (B) The amplitudes of the 118 rhythmic
genes are plotted against the phase. Genes with CRBSs are shown
with black diamonds, the other rhythmic genes are displayed with
gray diamonds. Core circadian clock genes are indicated. (C)
Phase distribution of rhythmic genes with and without CRBSs.
(TIFF)
Figure S6 CRBSs in promoters correlate with rhythmic
gene expression. Genes with CRBSs (n= 1373) were divided
into 352 genes with at least one CRBS close to the TSS (61 kb)
and 1021 genes with only distant CRBSs. The dark grey columns
represent the fractions of rhythmic genes (%) with distant and close
CRBSs. The light grey column represents the fraction of rhythmic
genes in a pool of 3480 randomly chosen genes without CRBS.
Rhythmic genes are significantly enriched in the fraction of genes
with close CRBS (p = 9.361024, Fisher’s Exact Test).
(TIFF)
Figure S7 Growth of U2OS cells in presence and
absence of rapamycin. 96-well plates were inoculated with
about 25.000 U2OS cells per well in the presence of 200 nM
rapamycin (in 1:100 DMSO) or with DMSO, for control (day 1).
The plates were incubated at 37uC and the number of cells were
counted at day 1, 2, 4 and 7 (n = 10).
(TIFF)
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